Comparison of Alogliptin and Metformin fixed-dose tablets once a morning vs. once an evening using Freestyle Libre Pro flash glucose Monitoring (AMPM study): An open-label randomized cross-over Trial.
Not Applicable
Recruiting
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000031445
- Lead Sponsor
- ational Hospital Organization Kyoto Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Type 1 diabetes 2) Undergoing insulin or GLP-1 agonist treatment 3) shift worker or night worker 4) Contraindications of medicine (Cr => 1.3mg/dL for men and => 1.2mg/dL for women) 5) Patients have History of hyper sensitivity 6) Not suitable for paticipate in this study from medical reason judged by a doctor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the blood glucose area under the curve
- Secondary Outcome Measures
Name Time Method 1) Average glucose (AG) 2) Average daily risk range (ADRR) 3) Morbus (M) value 4) 3-h post prandial (breakfast, lunch, dinner) blood glucose area under the curve (AUC) 5) Blood glucose (< 70mg/dl) area on the curve (AOC)